CLINICAL_TRIALS
research
· 2026-02-06
Clinical Trial Update: CLOZAPINE Response in Biotype-1 [Phase 4]
Summary
Phase 4 clinical trial evaluating Clozapine response in Biotype-1 is currently recruiting at UT Southwestern, studying schizophrenia, schizoaffective disorder, …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: RECRUITING